Incidence of Hemorrhagic Complications among Patients Treated with Thrombolytic in Erbil City, Iraq
Background: Recombinant tissue-type plasminogen activator is an option of treatment for suspected occlusive vascular thrombi and its sequel (transmural myocardial infarction, pulmonary embolism, and ischemic stroke). The most important concern associated with those patients is the fear of hemorrhagi...
Saved in:
| Main Authors: | Ahmed F. Hammad, Imad T. Abdulhafed, Abdulsalam R. Awad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Anbar
2020-12-01
|
| Series: | Al-Anbar Medical Journal |
| Subjects: | |
| Online Access: | https://amj.uoanbar.edu.iq/article_170955_c923e8b479beeee0aa8720460d617813.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Orolingual angioedema as a complication of systemic thrombolytic therapy with recombinant tissue plasminogen activator
by: E. A. Kovaleva, et al.
Published: (2023-11-01) -
Trial of Steroids in Retinal Assault: A Case Series
by: Sharanyaa Krishnamoorthy, et al.
Published: (2024-01-01) -
Successful Treatment of Arterial Thrombus in an Extremely Low-Birth-Weight Preterm Neonate
by: Petek G. Kayıran, et al.
Published: (2013-02-01) -
The Impact of the Fibrinolytic System on the Outcomes of Thrombolytic Therapy
by: R. E. Kalinin, et al.
Published: (2025-01-01) -
Stereotactic fibrinolysis of spontaneous intracerebral hematoma using infusion of recombinant tissue plasminogen activator
by: José Augusto Nasser, et al.
Published: (2002-06-01)